 
			| List | Section | Observation | 
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.2.5. Antituberculosis medicines | No observations | 
| PAHO Strategic Fund Medicine List | 2.3. Antituberculosis med. | Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. | 
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 07.03 ANTITUBERCULAR DRUGS | No observations | 
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | J. ANTI-INFECCIOSOS PARA USO SISTEMICO | No observations | 
| Haiti. National List of Essential Medicines | 06.02.04 Anti-tuberculosis drugs | Others observations: For use only in PLHIV on a protease inhibitor | 
| List | Section | Observation | 
|---|---|---|
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 03.02. ANTIBACTERIANOS | No observations | 
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 03.02. ANTIBACTERIANOS | No observations |